Newsroom

UNC Lineberger is recruiting participants for the Vanguard Study, which is evaluating a new type of blood test that screens for several types of cancer. This is the first study … Read more

This gift will fuel the next generation of cancer treatments, supporting all aspects of the UNC Lineberger Cellular Immunotherapy Program with an emphasis on clinical trials, expansion of the cellular … Read more

Ashok Krishnamurthy, PhD, collaborates with experts in informatics, biomedical, health and social science research to develop projects and programs that leverage the power of data science and scalable computing to … Read more

Pengda Liu, PhD, and colleagues are investigating a new way to tackle Ewing sarcoma, an aggressive and rare pediatric cancer that develops in the bones and soft tissues, while minimizing … Read more

Lynne I. Wagner, PhD, is co-author of a study for a nationwide clinical trial that reported doubled quit rates as part of a proactive, virtual tobacco treatment during cancer care.

Roy Dreyfuss received CAR T-cell therapy for Hodgkin lymphoma as part of a clinical trial in 2016. This was more than a year before the FDA approved this treatment for … Read more

A cancer diagnostic test developed by a group of researchers, including Charles Perou, PhD, has been found to accurately predict whether patients with breast cancer actually need chemotherapy – or … Read more

This grant supports research and community engagement to improve environmental health and well-being for people in North Carolina and beyond, including understanding how environmental exposures contribute to cancer risk and … Read more

Lindsey James, PhD, and colleagues are developing compounds that help eliminate cancer growth with the goal of creating more effective treatments for patients.

Caroline Thompson, PhD, MPH, and colleagues published study findings that more than one in four older adults are diagnosed with cancer inside an emergency department and that their chances of … Read more